Status:
COMPLETED
Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)
Lead Sponsor:
pico-tesla Magnetic Therapies, LLC
Conditions:
Parkinson's Disease
Eligibility:
All Genders
30-82 years
Brief Summary
An extension study for subjects with prior participation in previous resonator studies using low level magnetic fields to treat some of the symptoms of idiopathic Parkinson's Disease.
Eligibility Criteria
Inclusion
- Prior participation in pico-tesla pilot studies: NCT00779155 \& NCT00863226
- Willing and able to abstain from partaking in non-essential new treatments for Parkinson's disease symptoms during the course of participation of the study.
- Will and able to abstain from all non-essential new medications that could affect PD and/or any of its associated symptoms for the duration of the study.
- Willing to notify the investigator right away of any changes in medication use or therapies that is prescribed and deemed necessary by the subjects physicians.
- Adequate contraceptive measures for female subjects
- Capable of giving full written informed consent
Exclusion
- Not a participant in IRC#'s 07102 or 07021
- No active brain tumors, strokes, hydrocephalus
- Chronic pain not associated with PD
- Any other condition which might prevent subject from comfortably sitting for 1.5 hours
- Consumption of medications that can produce Parkinsonism type symptoms
- Major psychiatric disturbance
- Epilepsy
- HIv and other autoimmune disorders
- Cancer within last 2 years
- History of ECt
- Diabetic neuropathy
- Uncontrolled HTN
- Advanced Pulmonary disease
- Known heart conditions such as repetitive history of cardiac arrythmias
- Previous surgeries for PD
- Prosthetics comprised of ferrous materials
- Stents, only where there is also cardiac arrythmias, CHF, advanced valvular stenosis, unstable vital signs, extensive ischemic damage to heart muscle as a result of one or more heart attacks.
- Pacemakers
- Uncontrolled, unstable, or untreated medical illnesses which might potentially significantly affect the patient's health in the opinion of the investigator
- Consumption of more than 21 alcoholic drinks per week
- Pregnant, breast feeding or planning pregnancy
- Developmental disability or cognitive impairment
- Inability to maintain regular medication regime
- Inability to abstain from partaking in new non-essential PD tx., or medications
- Not willing to report physician mandated changes in medication and/or treatment
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00862537
Start Date
April 1 2008
End Date
April 1 2011
Last Update
July 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.